AIRLINK 85.80 Decreased By ▼ -1.40 (-1.61%)
BOP 5.04 Increased By ▲ 0.02 (0.4%)
CNERGY 4.13 Increased By ▲ 0.04 (0.98%)
DFML 37.73 Decreased By ▼ -0.17 (-0.45%)
DGKC 93.70 Decreased By ▼ -0.18 (-0.19%)
FCCL 23.76 Decreased By ▼ -0.01 (-0.04%)
FFBL 32.79 Increased By ▲ 0.12 (0.37%)
FFL 9.23 Decreased By ▼ -0.02 (-0.22%)
GGL 10.15 Increased By ▲ 0.12 (1.2%)
HASCOL 6.41 Decreased By ▼ -0.13 (-1.99%)
HBL 125.00 Increased By ▲ 3.08 (2.53%)
HUBC 148.25 Increased By ▲ 2.60 (1.79%)
HUMNL 10.88 Increased By ▲ 0.38 (3.62%)
KEL 4.70 Decreased By ▼ -0.04 (-0.84%)
KOSM 4.12 Decreased By ▼ -0.07 (-1.67%)
MLCF 39.60 Increased By ▲ 0.80 (2.06%)
OGDC 134.80 Decreased By ▼ -0.21 (-0.16%)
PAEL 25.30 Increased By ▲ 0.22 (0.88%)
PIBTL 6.30 Increased By ▲ 0.03 (0.48%)
PPL 121.20 Increased By ▲ 1.52 (1.27%)
PRL 24.55 Increased By ▲ 0.45 (1.87%)
PTC 12.21 Decreased By ▼ -0.01 (-0.08%)
SEARL 60.00 Increased By ▲ 0.20 (0.33%)
SNGP 64.98 Decreased By ▼ -0.02 (-0.03%)
SSGC 9.95 Decreased By ▼ -0.10 (-1%)
TELE 7.90 Increased By ▲ 0.03 (0.38%)
TPLP 9.67 Decreased By ▼ -0.07 (-0.72%)
TRG 64.60 Increased By ▲ 0.30 (0.47%)
UNITY 27.11 Increased By ▲ 0.06 (0.22%)
WTL 1.31 Decreased By ▼ -0.01 (-0.76%)
BR100 8,398 Increased By 88.5 (1.06%)
BR30 26,156 Increased By 205.8 (0.79%)
KSE100 79,445 Increased By 643.7 (0.82%)
KSE30 25,710 Increased By 272.1 (1.07%)

WASHINGTON: Testing in humans of an HIV vaccine that uses messenger RNA technology has begun, the biotech firm Moderna and the International AIDS Vaccine Initiative said Thursday. This Phase 1 trial is being carried out in the United States among 56 healthy adults who are HIV negative.

Despite four decades of research, doctors have yet to develop a vaccine to protect people from the virus that causes AIDS, which kills hundreds of thousands of people around the world each year.

Moderna begins trial of Omicron-specific vaccine booster

But hopes have been stirred with the success of mRNA technology, which allowed for the development of Covid-19 vaccines in record time, including one from Moderna.

Comments

Comments are closed.